Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jessie Hanrahan

Chief Regulatory Officer at Solid Biosciences Inc. (SLDB)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $297K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 18SEC SLDBSolid Biosciences Inc. Sell Plan 4,13474,318 held (−5%) $5.82 $24K -5.0%
Feb 6SEC SLDBSolid Biosciences Inc. Sell Plan 12,34870,327 held (−15%) $6.44 $80K -14.1%
Feb 2SEC SLDBSolid Biosciences Inc. Sell Plan 26,53582,675 held (−24%) $6.44 $171K -14.1%
Dec 4SEC SLDBSolid Biosciences Inc. Sell Plan 4,48326,660 held (−14%) $5.11 $23K +8.2%
  • Sell

    Chief Regulatory Officer Jessie Hanrahan sold $24K of SLDB at $5.82 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Regulatory Officer Jessie Hanrahan sold $80K of SLDB at $6.44 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Regulatory Officer Jessie Hanrahan sold $171K of SLDB at $6.44 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Regulatory Officer Jessie Hanrahan sold $23K of SLDB at $5.11 — pre-scheduled 10b5-1 plan sale.